Cytarabine 61703-0305

Product NDC

61703-0305

Manufacturer: Hospira, Inc.
Dosage Form: Injection, Solution
Route: Intrathecal, Intravenous, And Subcutaneous
Product Type: Human Prescription Drug
Marketing Start: June 4, 1990
Listing Expires: December 31, 2026
Application: ANDA071868

Need to source Cytarabine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Cytarabine	20 mg/mL

Drug Class

Nucleoside Metabolic Inhibitor [EPC]Nucleic Acid Synthesis Inhibitors [MoA]Nucleoside Metabolic Inhibitor [EPC]

Packaging Options(1)

61703-0305-38

5 VIAL, SINGLE-DOSE in 1 CARTON (61703-305-38) / 5 mL in 1 VIAL, SINGLE-DOSE (61703-305-58)

View →